Britain probing AstraZeneca-Alexion deal over competition concerns


Article content

Britain’s competition regulator said on Tuesday it has started a probe into AstraZeneca’s $39 billion takeover of U.S. drugmaker Alexion for possibly reducing competition in the UK market or elsewhere.

The Competition and Markets Authority said it was inviting comments from any interested party on the deal to help with its assessment. It has set a deadline of June 3 for the insight from any stakeholders.

Anglo-Swedish drugmaker AstraZeneca agreed to buy Alexion in December in its largest ever deal, diversifying away from its fast-growing cancer business in a bet on rare-disease and immunology drugs. (Reporting by Pushkala Aripaka in Bengaluru; Editing by Devika Syamnath)



Source link

Latest

Euro Manganese provides update on Chvaletice Manganese Project Permitting process, Demonstration Plant, feasibility study and commercial negotiations all remain on track

Highlights:The Project’s Final Environmental and Social Impact Assessment is on track for completion in the first quarter of 2022.Procurement of 97% of the...

EDF says informed of build-up of inert gases at Chinese nuclear facility

Article content SINGAPORE — French power group EDF said on Monday it had been informed of a build-up of inert gases at its...

How influencers make big money on Instagram through likes and engagement.

The influencer market is becoming saturated with time. But the game changers and the toppers are still a few. Just a decade ago, we...

CISSP Preparation Guide: What to Do and What Not to Do

The Certified Information Systems Security Professional (CISSP) exam is a valuable information security credential. According to Cyberseek, the demand for professionals certified in...